IP Library Granted Patent US 10,252,061
Granted Patent B2
US 10,252,061 · App. 15/851,787 · Granted Apr 9, 2019

Methods and systems for controlling blood pressure by controlling atrial pressure

Inventors: Yuval Mika (Closter, NJ); Darren Sherman (Fort Lauderdale, FL); Robert S. Schwartz (Inver Grove Heights, MN); Robert A. Van Tassel (Excelsior, MN); Daniel Burkhoff (Manhattan, NY)
Assignee: BackBeat Medical, Inc.
A61N1/36564A61F2/2412A61F2/2424A61N1/3682A61N1/3684A61N1/36117A61N1/36514A61N1/36528A61N1/36571A61N1/36578A61N1/36585A61F2250/0013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,252,061
App. No.
15/851,787
Granted
Apr 9, 2019
Kind
B2
Abstract

Systems and methods for controlling blood pressure by controlling atrial pressure and atrial stretch are disclosed. In some embodiments, a stimulation circuit may be configured to deliver a stimulation pulse to at least one cardiac chamber of a heart of a patient, and at least one controller may be configured to execute delivery of one or more stimulation patterns of stimulation pulses to the at least one cardiac chamber, wherein at least one of the stimulation pulses stimulates the heart such that an atrial pressure resulting from atrial contraction of an atrium overlaps in time a passive pressure build-up of the atrium, such that an atrial pressure of the atrium resulting from the stimulation is a combination of the atrial pressure resulting from atrial contraction and the passive pressure build-up and is higher than an atrial pressure of the atrium would be without the stimulation, and such that the blood pressure of the patient is reduced.

Claims (33)

1. A system for reducing blood pressure in a patient, the system comprising:

a stimulation circuit configured to deliver a stimulation pulse to at least one cardiac chamber of a heart of the patient; and

at least one controller configured to execute delivery of one or more stimulation patterns of stimulation pulses to the at least one cardiac chamber,

wherein at least one of the stimulation pulses stimulates the heart to cause increased atrial stretch of a wall of an atrium as a result of timing of atrial contraction and ventricular contraction, and

wherein the increased atrial stretch is higher than an atrial stretch would be without the stimulation, such that the blood pressure of the patient is reduced.

2. The system of claim 1 , wherein the increased atrial stretch reduces blood pressure through at least one of hormonal pathways or neural pathways.

3. The system of claim 1 , wherein, to cause the increased atrial stretch, the at least one of the stimulation pulses stimulates the heart such that the atrium contracts when pressure in a ventricle of the heart is about maximal so that active force of the atrial contraction increases atrial stretch above maximal passive atrial stretch caused by the ventricular contraction.

4. The system of claim 1 , wherein, to cause the increased atrial stretch, the at least one of the stimulation pulses stimulates a ventricle of the heart to cause the ventricle to commence contraction at such timing that peak atrial contraction occurs when the ventricle is near or at maximal stretch.

5. The system of claim 1 , wherein the at least one controller is configured to determine atrial stretch by measuring changes in dimension of the atrium.

6. The system of claim 1 , wherein, to cause the increased atrial stretch, the at least one of the stimulation pulses stimulates the heart to control timing of valve closure relative to atrial contraction.

7. The system of claim 1 , wherein the controller is configured to deliver the one or more stimulation patterns for a predetermined time interval, and to cause the increased atrial stretch to occur for a portion of the predetermined time interval.

8. The system of claim 1 , wherein the increased atrial stretch occurs transiently during the stimulation.

9. The system of claim 1 , wherein, to cause the increased atrial stretch, the at least one of the stimulation pulses stimulates the heart such that an atrial stretch resulting from atrial contraction overlaps in time a passive atrial stretch.

10. The system of claim 9 , wherein the passive atrial stretch occurs during isovolumic contraction of a ventricle of the heart.

11. The system of claim 9 , wherein the passive atrial stretch occurs during a rapid ejection phase of a ventricle of the heart.

12. The system of claim 1 , wherein, to cause the increased atrial stretch, the at least one of the stimulation pulses stimulates the heart such that a maximum of atrial pressure resulting from atrial contraction overlaps in time a maximum passive atrial stretch.

13. The system of claim 12 , wherein the maximum passive atrial stretch occurs at a time between about 25 ms after start of an isovolumic phase and about 10 ms after end of the isovolumic phase.

14. The system of claim 12 , wherein the maximum passive atrial stretch occurs between a start of a second half of an isovolumic phase and a first approximately 10 ms of a rapid ejection phase.

15. The system of claim 1 , wherein the one or more stimulation patterns comprise pacing the atrium and a ventricle of the heart at a substantially equal rate.

16. The system of claim 1 , wherein the one or more stimulation patterns comprise pacing the atrium at a rate higher than a rate at which a ventricle of the heart is paced.

17. The system of claim 1 , wherein the at least one of the stimulation pulses comprises stimulating the atrium of the heart such that the atrium contracts only once during a single cardiac cycle.

18. The system of claim 1 , wherein the timing corresponds to an atrioventricular delay of between approximately 60 ms and approximately 0 ms.

19. A method, carried out with an implanted heart muscle stimulator associated with a heart of a patient, for reducing blood pressure of the patient, the method comprising:

delivering one or more stimulation patterns of stimulation pulses to at least one cardiac chamber of the heart of the patient; and

stimulating the heart with at least one of the stimulation pulses to cause increased atrial stretch of a wall of an atrium as a result of timing of atrial contraction and ventricular contraction,

wherein the increased atrial stretch is higher than an atrial stretch would be without the stimulation, such that the blood pressure of the patient is reduced.

20. The method of claim 19 , wherein, to cause the increased atrial stretch, the at least one of the stimulation pulses stimulates the heart such that the atrium contracts when pressure in a ventricle of the heart is about maximal so that active force of the atrial contraction increases atrial stretch above maximal passive atrial stretch caused by the ventricular contraction.

21. A system for reducing blood pressure in a patient, the system comprising:

a stimulation circuit configured to deliver a stimulation pulse to at least one cardiac chamber of a heart of the patient; and

at least one controller configured to execute delivery of one or more stimulation patterns of stimulation pulses to the at least one cardiac chamber,

wherein at least one of the stimulation pulses stimulates the heart to provide a timing of atrial contraction and ventricle contraction that increases atrial stretch, and

wherein the increased atrial stretch is higher than an atrial stretch would be without the stimulation, such that the blood pressure of the patient is reduced.

22. The system of claim 21 , wherein the at least one of the stimulation pulses stimulates the heart such that a maximum of atrial stretch resulting from atrial contraction overlaps in time a maximum passive atrial stretch.

Assignments (7)
SECURITY INTEREST Recorded Aug 7, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: MEDTRONIC, INC.
Reel/Frame 072341/0075 →
SECURITY INTEREST Recorded Aug 4, 2025
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; BACKBEAT MEDICAL, LLC; CALIBER THERAPEUTICS, LLC
To: LIGAND PHARMACEUTICALS, INC.
Reel/Frame 072359/0219 →
SECURITY INTEREST Recorded Nov 6, 2024
From: ORCHESTRA BIOMED HOLDINGS, INC.; ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC
To: HERCULES CAPITAL, INC.
Reel/Frame 069312/0758 →
RELEASE OF IP SECURITY INTEREST Recorded Oct 9, 2023
From: AVENUE VENTURE OPPORTUNITIES FUND, L.P.
To: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
Reel/Frame 065192/0001 →
SECURITY AGREEMENT Recorded Jun 6, 2022
From: ORCHESTRA BIOMED, INC.; CALIBER THERAPEUTICS, LLC; BACKBEAT MEDICAL, LLC; FREEHOLD SURGICAL, LLC; ACCELERATED TECHNOLOGIES, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND, L.P., AS AGENT
Reel/Frame 060286/0021 →
ENTITY CONVERSION Recorded Feb 13, 2020
From: BACKBEAT MEDICAL, INC.
To: BACKBEAT MEDICAL, LLC
Reel/Frame 051930/0075 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2018
From: MIKA, YUVAL; SHERMAN, DARREN; SCHWARTZ, ROBERT S.; VAN TASSEL, ROBERT A.; BURKHOFF, DANIEL
To: BACKBEAT MEDICAL, INC.
Reel/Frame 044894/0767 →
Priority Claims (1)
WO PCT/US2013/076600 · Dec 19, 2013 · international
Continuity (4)
Continuation 15372603 · Dec 8, 2016
Continuation 14667931 · Mar 25, 2015
Division 14427478
Related Publication 20180185652A1 · Jul 5, 2018
Cited By (6)
US 12,208,271 US 12,239,839 US 12,246,180 US 12,440,653 US 12,458,805 US 12,605,554